It is well-known that APOE ε4 is an established risk factor for cognitive decline and the development of dementia.45 In the current study, we found that the association of higher CR indicator with slower cognitive decline was present only among APOE ε4 noncarriers, but not in APOE ε4 carriers. The gene discussed is APOE; the disease is dementia.